Caredx

CDNA

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding

In their latest 13F (Q3 2026)

See who

Value held

$17.1m

Combined value at quarter end

Last quarter

1 bought

0 sold or trimmed

Price at Q2 ’26 end

$28.50

+64.2% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+101.1%Q3 ’24

-31.4%Q4 ’24

-17.1%Q1 ’25

+10.1%Q2 ’25

-25.6%Q3 ’25

+29.6%Q4 ’25

-7.9%Q1 ’26

+64.2%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

1Q4 ’23

1Q1 ’24

1Q2 ’24

1Q3 ’24

1Q4 ’24

1Q1 ’25

1Q2 ’25

1Q3 ’25

1Q4 ’25

1Q1 ’26

1Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes Caredx.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Caredx

First Eagle Investment Management	0.0%$17.1m	$17.1m	Added +4.0%	18 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works

From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.

Sort by

Insider purchases and sales of Caredx
		Bought or sold				Filing
5 Aug 2026	Bickerstaff GeorgeDirector	▼ Sold	20,000	$46.28	$926k	Form 4
5 Aug 2026	Novack Jeffrey AdamSecretary and General Counsel	▼ Sold	2,188	$46.15	$101k	Form 4
5 Aug 2026	Novack Jeffrey AdamSecretary and General Counsel	▼ Sold	500	$46.75	$23k	Form 4
4 Aug 2026	Goldberg MichaelDirector	▼ Sold	44,700	$47.06	$2.1m	Form 4
4 Aug 2026	Cournoyer ChristineDirector	▼ Sold	16,000	$46.94	$751k	Form 4
16 Jul 2026	Hanna John Walter JrPresident and CEO	▼ Sold	68,000	$39.01	$2.7m	Form 4
16 Jul 2026	Hanna John Walter JrPresident and CEO	▼ Sold	50,000	$36.11	$1.8m	Form 4
16 Jul 2026	Valantine HannahDirector	▼ Sold	28,679	$36.14	$1.0m	Form 4
16 Jul 2026	Valantine HannahDirector	▼ Sold	100	$36.55	$4k	Form 4

About the company

Sector: Health care · Services-Medical Laboratories
Incorporated in: Delaware
Financial year ends: 31 December
Shares outstanding: 52m at 27 Jul 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

$22.1m2013

$28.1m2015

$48.3m2017

$127m2019

$296m2021

$280m2023

$380m2025

Caredx revenue and net income by year
Year	Revenue	Net income
2025	$380m	−$21.4m
2024	$334m	$52.5m
2023	$280m	−$190m
2022	$322m	−$76.6m
2021	$296m	−$30.7m
2020	$192m	−$18.7m
2019	$127m	−$22.0m
2018	$76.6m	−$46.8m
2017	$48.3m	−$55.5m
2016	$40.6m	−$39.5m
2015	$28.1m	−$13.7m
2014	$27.3m	$781k
2013	$22.1m	−$3.5m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.